Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIxico Regulatory News (IXI)

Share Price Information for Ixico (IXI)

Share Price is delayed by 15 minutes
Get Live Data
8.65    0.00 (0.00%)
Bid:
8.30
Ask:
9.00
Spread: 0.70 (8.434%)
Market Cap: £18.86m
IXI Live PriceLast checked at - London Stock Exchange

Intraday Ixico Share Chart

PDMR Transaction

25 Mar 2021 09:14

RNS Number : 4793T
IXICO plc
25 March 2021
 

25 March 2021

 

IXICO plc

("IXICO" or the "Company")

 

Director/PDMR Dealing

 

 

IXICO plc (AIM: IXI), the data analytics company delivering insights in neuroscience, announces that Mark Warne, Non-Executive Director, today purchased 14,250 ordinary shares in the Company at an average price of 63 pence.

 

 

For further information please contact:

 

IXICO plc +44 20 3763 7499

Giulio Cerroni, Chief Executive Officer

Grant Nash, Chief Financial Officer

 

Cenkos Securities plc (Nominated adviser and sole broker) +44 20 7397 8900

Giles Balleny / Max Gould (Corporate Finance)

Michael F Johnson / Russell Kerr (Sales)

 

Walbrook PR Ltd

+44 (0)20 7933 8780

 

Paul McManus / Lianne Cawthorne /

IXICO@walbrookpr.com

Alice Woodings

 

The below makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Mark Warne

2

Reason for notification

On market purchase

a.

Position/Status

Non-Executive Director

b.

Initial notification/

Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

IXICO plc

b.

LEI

2138005M1F59O6HWSA97

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary shares of 1p each

ISIN: GB00BCLY7L40

 

b.

Nature of the transaction

 Purchase of ordinary shares

c.

Price(s) and volume(s)

Price(s) per share

Volume(s)

£0.66

250 shares

£0.64

1500 shares

£0.65

1500 shares

£0.63

1500 shares

£0.61

1500 shares

£0.61

1500 shares

£0.63

1500 shares

£0.62

5000 shares

 

 

d.

Aggregated information

- Aggregated Volume

- Price

 

14,250 shares

£0.63

e.

Date of the transaction

24 March 2021

f.

Place of the transaction

London Stock Exchange, AIM Market

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHKELBLFXLBBBK
Date   Source Headline
11th Mar 201410:04 amRNSHolding(s) in Company
7th Mar 20142:35 pmRNSInternational alliance with VirtualScopics
28th Feb 20147:00 amRNSPublication of annual report and business update
6th Feb 20147:00 amRNSAppointment of Joint Broker
13th Jan 20149:51 amRNSPresents at Dementia Challenge seminar in Beijing
2nd Jan 20145:08 pmRNSHolding(s) in Company
17th Dec 20137:00 amRNSBusiness and trading update
13th Dec 20137:00 amRNSTSB Grant to Develop Dementia Diagnosis Products
11th Dec 20137:00 amRNSDementia diagnosis tool launch and InHealth update
10th Dec 20137:00 amRNSAttending G8 Global CEO Initiative on Alzheimer's
2nd Dec 201310:03 amRNSIXICO signs MOU with Beijing UMP
18th Nov 20136:00 pmRNSDirector/PDMR Shareholding
1st Nov 20134:01 pmRNSDirector/PDMR Shareholding
31st Oct 201311:26 amRNSDirector/PDMR Shareholding
22nd Oct 201312:29 pmRNSHolding(s) in Company
21st Oct 20131:22 pmRNSDirector/PDMR Shareholding
17th Oct 20133:08 pmRNSHolding(s) in Company
15th Oct 20137:00 amRNSFirst Day of Dealings
14th Oct 201312:18 pmRNSResult of General Meeting
14th Oct 201311:08 amRNSSchedule 1 update - Phytopharm Plc
11th Oct 20131:48 pmRNSSch 1 Update - Phytopharm plc
3rd Oct 20139:23 amRNSHolding(s) in Company
1st Oct 20137:00 amRNSDirector/PDMR Shareholding
30th Sep 20132:45 pmRNSSchedule 1 - Phytopharm Plc
27th Sep 20133:17 pmRNSDirector/PDMR Shareholding
24th Sep 20137:30 amRNSRestoration - Phytopharm Plc
23rd Sep 20137:05 amRNSIXICO expands into digital healthcare
23rd Sep 20137:00 amRNSProposed acquisition of IXICO Limited
29th Aug 201312:01 pmRNSSchedule 1 update - Phytopharm plc
9th Aug 20137:00 amRNSInterim Management Statement
8th Aug 201312:23 pmRNSSchedule 1 update - Phytopharm plc
8th Aug 201311:00 amRNSChange to AIM Admission Timetable
6th Aug 20132:15 pmRNSSchedule 1 - Phytopharm plc
5th Aug 20132:16 pmRNSResult of General Meeting
19th Jul 201311:06 amRNSCancellation of Listing and Admission to AIM
23rd May 20137:00 amRNSInterim Results
21st May 20137:45 amRNSStatement re. Suspension
21st May 20137:30 amRNSTemporary Suspension - Phytopharm Plc
17th May 20139:23 amRNSNotice of Results
27th Mar 201310:15 amRNSAGM Statement
26th Mar 20137:00 amRNSStrategic Review Update
15th Mar 201312:06 pmRNSHolding(s) in Company
18th Feb 20137:00 amRNSResearch Update
13th Feb 20131:59 pmRNSHolding(s) in Company
5th Feb 20137:00 amRNSInterim Management Statement
4th Feb 201311:34 amRNSNotice of AGM
19th Dec 20129:21 amRNSAnnual Financial Report
18th Dec 20127:00 amRNSCogane in ALS Update
17th Dec 201211:00 amRNSBlocklisting Interim Review
22nd Nov 20127:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.